Single-dose administration of an aromatase inhibitor for ovarian stimulation
Authors:
- Robert F. CasperRCRobert F. Casper
- 1 January 2005
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 83 (1) , 229-231
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Aromatase Inhibition Reduces the Dose of Gonadotropin Required for Controlled Ovarian HyperstimulationJournal of the Society for Gynecologic Investigation, 2004
- Effects of letrozole on superovulation with gonadotropins in women undergoing intrauterine inseminationFertility and Sterility, 2003
- Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertilityHuman Reproduction, 2003
- Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor respondersFertility and Sterility, 2002
- Efficacy of Superovulation and Intrauterine Insemination in the Treatment of InfertilityNew England Journal of Medicine, 1999
- Absolute bioavailability of letrozole in healthy postmenopausal womenBiopharmaceutics & Drug Disposition, 1997
- COMPARATIVE BIOAVAILABILITY OF LETROZOLE UNDER FED AND FASTING CONDITIONS IN 12 HEALTHY SUBJECTS AFTER A 2·5 MG SINGLE ORAL ADMINISTRATIONBiopharmaceutics & Drug Disposition, 1997
- Critical reappraisal of the clinical effectiveness of different methods of assisted fertilizationJournal of Endocrinological Investigation, 1990
- Unexplained infertility—the value of Pergonal superovulation combined with intrauterine inseminationFertility and Sterility, 1988
- Pharmacologic induction of multiple follicular development improves the success rate of artificial insemination with husband’s semen in couples with male-related or unexplained infertilityFertility and Sterility, 1987